1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Rodero-Romero A, Fernández-Velasco JI, Monreal E, Sainz-Amo R, Álvarez-Lafuente R, Comabella M, Ramió-Torrentà L, García-Domínguez JM, Villarrubia N, Sainz de la Maza S, Domínguez-Mozo M, Quiroga-Varela A, Chico-García JL, Rodriguez-Jorge F, Veiga-Gonzalez JL, Roldán-Santiago E, Espiño M, Rodríguez-Martín E, Álvarez G, Masjuan J, Montalban X, Costa-Frossard L, Villar LM.

    Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis.

    Frontiers in immunology . 16: 1648725-1648725.

    [doi:10.3389/fimmu.2025.1648725]

  • Gajate Martín L, de la Hoz I, Martín M, Fernández C, Martín Grande A, Parise D, Villahoz J, Gómez M, Espiño M, Pastor O, Rodríguez Gandía MÁ, Nuño J.

    A randomized trial of ascorbic acid for the prevention of post-reperfusion syndrome during liver transplantation.

    Hepatology Communications . 9(8): .

    [doi:10.1097/HC9.0000000000000777]

  • Monreal E, Fernández-Velasco JI, Sainz de la Maza S, Espiño M, Villarrubia N, Roldán-Santiago E, Aladro Y, Cuello JP, Ayuso-Peralta L, Rodero-Romero A, Chico-García JL, Rodríguez-Jorge F, Quiroga-Varela A, Rodríguez-Martín E, Pilo de la Fuente B, Martín-Ávila G, Martínez-Ginés ML, García-Domínguez JM, Rubio L, Llufriu S, Comabella M, Montalban X, Álvarez-Bravo G, Veiga-González JL, Masjuan J, Costa-Frossard L, Villar LM.

    Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(14): .

    [doi:10.3390/ijms26146898]

  • Gómez-Ballesteros R, Sainz de la Maza S, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco-Quílez MR, Dotor García-Soto J, Rodríguez-Regal A, Navarro-Cantó L, Agüera E, Garcés-Redondo M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, Castillo-Triviño T, Maurino J.

    Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

    Frontiers in psychiatry . 16: 1565150-1565150.

    [doi:10.3389/fpsyt.2025.1565150]

  • Cayuela L, de Albóniga-Chindurza A, Gómez Enjuto S, Lapeña-Motilva J, Sainz de la Maza S, González García A, Cayuela A.

    Multiple sclerosis mortality trends in Spain from 1981 to 2020.

    Neurologia . 40(6): 558-566.

    [doi:10.1016/j.nrleng.2025.06.006]

  • Cayuela L, García-Muñoz C, Sainz de la Maza S, Cayuela A.

    Prevalence of multiple sclerosis in Spain. Estimates from the Primary Care Clinical Database (BDCAP).

    Neurologia . 40(5): 447-455.

    [doi:10.1016/j.nrleng.2025.04.010]

  • Dema M, Eixarch H, Hervera A, Castillo M, Villar LM, Montalban X, Espejo C.

    Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of Immunosenescence.

    Aging Cell . 24(5): .

    [doi:10.1111/acel.14491]

  • Oreja-Guevara C, Meca-Lallana JE, Gómez-Estévez I, Ara JR, Pérez MÁH, Gil JG, Torres AMA, de la Fuente BP, Ramió-Torrentà L, Madueño SE, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Valcárcel MA, Ginés MLM, Montero YEB, Real AML, González-Quintanilla V, de Silanes CL, Martínez-Rodríguez JE, Costa-Frossard L, Redondo MG, Fontcuberta AL, Castellanos-Pinedo F, Merino JAG, Fernández CM, Castillo-Triviño T, Meca-Lallana V, Martínez JP, Rodríguez-Antigüedad A, González JMP, Morales EA, Molina IP, Sánchez DMS, Varo NH, Vázquez MA, Barrios JMR, Río J.

    Economic burden of secondary progressive multiple sclerosis: DISCOVER study.

    BMC HEALTH SERVICES RESEARCH . 25(1): 525-525.

    [doi:10.1186/s12913-025-12592-1]

  • Piñar-Morales R, Calle-Calle R, Carrasco-Garcia M, Davila-Arias C, Villar-Guimerans LM, Barrero Hernandez FJ.

    Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumab.

    FRONTIERS IN PHARMACOLOGY . 16: 1571699-1571699.

    [doi:10.3389/fphar.2025.1571699]

  • Dominguez-Mozo MI, López-Mecández D, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Pilo B, Montalbán X, Comabella M, Casanova-Peño I, González-Suárez I, Martínez-Ginés ML, García-Domínguez JM, García-Calvo E, Machuca-Marcos A, Luque-Garcia JL, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.

    Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile.

    Annals of Clinical and Translational Neurology . 12(3): 478-490.

    [doi:10.1002/acn3.52259]

  • Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Avilés AC, Arrambide G, Carbonell-Mirabent P, Gutierrez L, Cobo-Calvo Á, Tur C, Villacieros-Álvarez J, Vidal-Jordana Á, Castilló J, Galán I, Espiño M, Ariño H, Bollo L, Rodríguez Barranco M, Midaglia LS, Carvajal R, Villarrubia N, Fernández Velasco JI, Rodríguez Acevedo B, Costa Frossard LF, Vilaseca A, Auger C, Zabalza A, Sainz de la Maza S, Mongay-Ochoa N, Río J, Sastre-Garriga J, Rovira À, Tintoré M, Villar LM, Montalban X.

    Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 12(2): .

    [doi:10.1212/NXI.0000000000200370]

  • García-Domínguez JM, Maurino J, Meca-Lallana JE, Landete L, Meca-Lallana V, García-Arcelay E, Agüera-Morales E, Caminero AB, Martínez-Yélamos S, Querol L, Medrano N, Gómez-Ballesteros R, Villar LM, Monreal E, Saposnik G.

    Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment.

    Journal of Personalized Medicine . 15(2): .

    [doi:10.3390/jpm15020069]

  • Martínez García B, Chico García JL, Pérez Gil D, Garay Albízuri P, Llanes Ferrer A, García Alcántara G, Cabañas Engenios G, Matute Lozano MC, de Felipe Mimbrera A, Vera Lechuga R, Cruz Culebras A, Carrión Sánchez I, Fernández-Golfín C, Masjuan J, García Madrona S.

    Grading Right-to-Left Shunt With Transforaminal Doppler: A Valid Approach in Patients With Cryptogenic Stroke.

    J NEUROIMAGING . 35(1): .

    [doi:10.1111/jon.70023]

  • Comabella M, Hegen H, Villar LM, Rejdak K, Sao-Avilés A, Behrens M, Sastre-Garriga J, Mongay N, Berek K, Martínez-Yelamos S, Pérez-Miralles F, Abdelhak A, Bachhuber F, Tumani H, Lycke J, Carbonell-Mirabent P, Valls-Carbó A, Rosenstein I, Alvarez-Lafuente R, Castillo-Triviño T, Otaegui D, Llufriu S, Blanco Y, Sánchez-López AJ, García-Merino A, Fissolo N, Gutiérrez L, Villacieros-Álvarez J, Monreal E, Wiendl H, Montalban X, Lünemann JD.

    Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.

    JOURNAL OF NEUROLOGY . 272(1): 26-26.

    [doi:10.1007/s00415-024-12763-w]

  • Sainz-Amo R, Rodero-Romero A, Monreal E, Chico-García JL, Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Veiga-González JL, de la Maza SS, Masjuan J, Costa-Frossard L, Villar LM.

    Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(23): .

    [doi:10.3390/ijms252313153]

  • Monreal E, Fernández-Velasco JI, Álvarez-Lafuente R, Sainz de la Maza S, García-Sánchez MI, Llufriu S, Casanova B, Comabella M, Martínez-Yélamos S, Galimberti D, Ramió-Torrentà L, Martínez-Ginés ML, Aladro Y, Ayuso L, Martínez-Rodríguez JE, Brieva L, Villarrubia N, Eichau S, Zamora J, Rodero-Romero A, Espiño M, Blanco Y, Saiz A, Montalbán X, Tintoré M, Domínguez-Mozo MI, Cuello JP, Romero-Pinel L, Ghezzi L, Pilo de la Fuente B, Pérez-Miralles F, Quiroga-Varela A, Rubio L, Rodríguez-Jorge F, Chico-García JL, Sainz-Amo R, Masjuan J, Costa-Frossard L, Villar LM.

    Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.

    Brain . 147(12): 4084-4093. Nº de citas: 2

    [doi:10.1093/brain/awae260]

  • Meca-Lallana JE, Robles R, Landete L, Téllez N, García-Domínguez JM, Garcés P, Costa-Frossard L.

    A Clinical Care Algorithm for Detecting Progression in Multiple Sclerosis: RetratEMos Project.

    Cureus . 16(11): 74001-74001.

    [doi:10.7759/cureus.74001]

  • Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Gracia-Gil J, Fernández E, Meca-Lallana V, Díaz-Pérez C, Sainz de la Maza S, Pacheco EM, Quiroga A, Ramió-Torrentà L, Martínez-Yélamos S, Bau L, Monreal E, López-Real A, Rodero-Romero A, Borrega L, Díaz S, Eguía P, Espiño M, Chico-García JL, Barrero FJ, Martínez-Ginés ML, García-Domínguez JM, De la Fuente S, Moreno I, Sainz-Amo R, Mañé-Martínez MA, Caminero A, Castellanos F, Gómez López A, Labiano-Fontcuberta A, Ayuso L, Abreu R, Hernández MÁ, Meca-Lallana J, Martín-Aguilar L, Muriel García A, Masjuan J, Costa-Frossard L, Villar LM.

    Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

    Frontiers in immunology . 15: 1480676-1480676.

    [doi:10.3389/fimmu.2024.1480676]